Alzheimer's disease is a major health problem in developed countries. Approximately 10–
15% of direct costs in dementia are attributed to pharmacological treatment, and only 10 …

To provide healthcare professionals with a comprehensive assessment of donepezil 23 mg
and its role in treating A lzheimer's disease (AD), the Donepezil 23 mg Expert Working …

drugs to be used in patients. Randomized, con trolled trials (RCTs), prospective outcomes
stud ies and comparative effectiveness studies are likely to be resource prohibitive in the …

Within the pharmaceutical industry, the application of clinical pharmacogenomics promises
to enhance the discovery of drug response markers, reduce the size and expense of clinical …

Now 15 years ago, in 2003, the International Human Genome Sequencing Consortium
proudly announced that the Human Genome Project had been completed. This endeavor …

Major depressive disorder (MDD) is an emergent cause of personal and socio‐economic
burden, both for the high prevalence of the disorder and the unsatisfying response rate of …

Pharmacogenomics has recently become an integral part of the drug development process.
The pharmacogenomics revolution comes at a time when pharmaceutical companies are …

Role of Pharmacogenomic Biomarkers In Predicting and Improving Drug Response - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background It has been estimated that the human genome harbors about 30,000 protein-
coding genes. Within these proteins we find transporters, metabolizing enzymes, and …

Remimazolam is a new ultra‐short‐acting benzodiazepine used to induce and maintain
anesthesia and procedural sedation. Its compound structure is similar to midazolam's …